Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
|---|---|---|---|---|---|---|---|---|---|
Patent 7172750 was granted and assigned to Millennium Pharmaceuticals on February, 2007 by the United States Patent and Trademark Office. | 7172750 | February 6, 2007 | |||||||
Patent 7301016 was granted and assigned to Millennium Pharmaceuticals on November, 2007 by the United States Patent and Trademark Office. | 7301016 | November 27, 2007 | |||||||
Patent 7208152 was granted and assigned to Millennium Pharmaceuticals on April, 2007 by the United States Patent and Trademark Office. | 7208152 | April 24, 2007 | |||||||
Patent 7294482 was granted and assigned to Millennium Pharmaceuticals on November, 2007 by the United States Patent and Trademark Office. | 7294482 | November 13, 2007 | |||||||
Patent 7482147 was granted and assigned to Millennium Pharmaceuticals on January, 2009 by the United States Patent and Trademark Office. | 7482147 | January 27, 2009 | |||||||
Patent 7101714 was granted and assigned to Millennium Pharmaceuticals on September, 2006 by the United States Patent and Trademark Office. | 7101714 | September 5, 2006 | |||||||
11498708 | November 15, 2022 | ||||||||
Patent 7029895 was granted and assigned to Millennium Pharmaceuticals on April, 2006 by the United States Patent and Trademark Office. | 7029895 | April 18, 2006 | |||||||
Patent 7285620 was granted and assigned to Millennium Pharmaceuticals on October, 2007 by the United States Patent and Trademark Office. | 7285620 | October 23, 2007 | |||||||
Patent 6869775 was granted and assigned to Millennium Pharmaceuticals on March, 2005 by the United States Patent and Trademark Office. | 6869775 | March 22, 2005 | |||||||
Patent 7033780 was granted and assigned to Millennium Pharmaceuticals on April, 2006 by the United States Patent and Trademark Office. | 7033780 | April 25, 2006 | |||||||
Patent 7351566 was granted and assigned to Millennium Pharmaceuticals on April, 2008 by the United States Patent and Trademark Office. | 7351566 | April 1, 2008 | |||||||
Patent D1010817 was granted and assigned to Millennium Pharmaceuticals on January, 2024 by the United States Patent and Trademark Office. | D1010817 | January 9, 2024 | |||||||
Patent 7776577 was granted and assigned to Millennium Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office. | 7776577 | August 17, 2010 | |||||||
Patent 7459530 was granted and assigned to Millennium Pharmaceuticals on December, 2008 by the United States Patent and Trademark Office. | 7459530 | December 2, 2008 | |||||||
Patent 7160694 was granted and assigned to Millennium Pharmaceuticals on January, 2007 by the United States Patent and Trademark Office. | 7160694 | January 9, 2007 | |||||||
Patent 6979564 was granted and assigned to Millennium Pharmaceuticals on December, 2005 by the United States Patent and Trademark Office. | 6979564 | December 27, 2005 | |||||||
Patent 8252915 was granted and assigned to Millennium Pharmaceuticals on August, 2012 by the United States Patent and Trademark Office. | 8252915 | August 28, 2012 | |||||||
Patent 7799898 was granted and assigned to Millennium Pharmaceuticals on September, 2010 by the United States Patent and Trademark Office. | 7799898 | September 21, 2010 | |||||||
Patent 7534579 was granted and assigned to Millennium Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office. | 7534579 | May 19, 2009 | |||||||
Patent 8444987 was granted and assigned to Millennium Pharmaceuticals on May, 2013 by the United States Patent and Trademark Office. | 8444987 | May 21, 2013 | |||||||
Patent 7452980 was granted and assigned to Millennium Pharmaceuticals on November, 2008 by the United States Patent and Trademark Office. | 7452980 | November 18, 2008 | |||||||
Patent 7214502 was granted and assigned to Millennium Pharmaceuticals on May, 2007 by the United States Patent and Trademark Office. | 7214502 | May 8, 2007 | |||||||
Patent 7041474 was granted and assigned to Millennium Pharmaceuticals on May, 2006 by the United States Patent and Trademark Office. | 7041474 | May 9, 2006 | |||||||
Patent 7385036 was granted and assigned to Millennium Pharmaceuticals on June, 2008 by the United States Patent and Trademark Office. | 7385036 | June 10, 2008 |